BIORA THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biora Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q3 2024.
  • Biora Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $2.02M, a 22.2% decline year-over-year.
  • Biora Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $7.32M, a 31.3% decline year-over-year.
  • Biora Therapeutics, Inc. annual Interest Expense for 2023 was $9.82M, a 10.7% decline from 2022.
  • Biora Therapeutics, Inc. annual Interest Expense for 2022 was $11M, a 13% decline from 2021.
  • Biora Therapeutics, Inc. annual Interest Expense for 2021 was $12.6M, a 27.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.32M $2.02M -$576K -22.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $7.9M $711K -$1.99M -73.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $9.89M $2.76M +$77K +2.87% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $9.82M $1.84M -$845K -31.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $10.7M $2.59M -$181K -6.53% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $10.8M $2.7M -$69K -2.49% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $10.9M $2.68M -$80K -2.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $11M $2.69M +$529K +24.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $10.5M $2.77M -$685K -19.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11.1M $2.77M -$730K -20.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $11.9M $2.76M -$760K -21.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $12.6M $2.16M -$511K -19.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $13.1M $3.46M +$1M +40.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $12.1M $3.5M +$1.01M +40.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $11.1M $3.52M +$1.22M +52.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $9.92M $2.67M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $2.46M +$136K +5.86% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.49M +$207K +9.07% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $2.32M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.28M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.